David joined Ampersand in 2005. Previously, he was General Counsel of ArQule (Nasdaq: ARQL), where he participated in the acquisition of Ampersand portfolio company Cyclis. Prior to ArQule, he served as Senior Counsel in.... more info >
Ampersand Ventures is a mid-market private equity group that concentrates on growth equity investment opportunities in the healthcare and industrial sectors. Specific areas of interests within healthcare include lab pro.... more info >
2,000+ Private Equity Firms
25,000+ Portfolio Companies
16,000+ Firm Contacts
Easy to use search tools
Save searches/Create project lists
Export info